healthcare professional for medical advice
cause platelet activation
bruise
month
use of unfractionated heparin
wound hematoma
limb gangrene
tingle sensation
start heparin
leg weakness
dark brown urine
chest
other anticoagulant
spinal hematoma
release of platelet derive procoagulant microparticle
low molecular weight heparin
bladder function
pain at injection site
transient ischemic attack
woman
hit
weakness
restart heparin
skin necrosis
joint
prolonged bleeding from cut
abrupt decrease in platelet
nausea
health care professional
develop hit associate thrombosis
skin rash
nonwhite
useful substitute for heparin
unexplained pain
dizziness
danaparoid
constipation
problem with bowel
fever
hemorrhage
vaginal bleeding
septic shock
thrombocytopenia
thrombin
postoperative blood loss
platelet
medicine
back pain
body
shortness of breath
burn
bleed gum
bleed
active ingredient
heparin
injection site discomfort
numbness
nosebleed
paralysis
possible danaparoid associate mortality
increase menstrual flow
undergo spinal epidural anesthesia
swallow
antibody
difficulty in breathing
circulate heparin pf igg immune complex
tarry stool
lmwh
cross reactivity with heparin induce antibody than some low molecular weight heparin
severity of thrombocytopenia
permanent paralysis
tickle
use
decrease in platelet count
groundlike material
higher risk
unusual bruise
pf
type
circulate
hemostasis
factor
immediate anticoagulation
indwell
venous thrombosis
indwell epidural catheter
vomiting of blood
fda
heparin pf igg
concomitant use of platelet inhibitor
immune complex
platelet factor
unfractionated heparin
cough up blood
fatal bleeding episode
risk of these event
headache
orgaran
discontinuation
coffee
stroke
positive cross reactivity with heparin induce antibody
exacerbation of venous thromboembolism
develop heparin induce thrombocytopenia
develop
medical attention
heparin dependent igg antibody
ige
hypersensitivity
test
specific platelet protein
prick
swell
incidence
abdomen
discomfort
puncture
activate platelet
heparinoid
subcutaneous injection danaparoid
lower body weight
high cross reactivity
heparin induce thrombocytopenia
thrombosis
muscle
risk for long term